This case describes a new, potentially targetable molecular alteration in a uterine leiomyoma, distinct from the common <i>MED12</i>-mutated pathway, highlighting the underlying molecular heterogeneity of these common tumors. The gene discussed is MED12; the disease is uterine corpus leiomyoma.